Studies Open for Enrollment
The Sickle Cell Program of Children's Hospital of Pittsburgh of UPMC is committed to participating in clinical research studies to improve the lives of patients with sickle cell disease. Contact Donna Scalercio at donna.scalercio@chp.edu for more information about the studies listed below.
Studies Currently Open For Enrollment:
- Bone Marrow Transplantation for sickle cell disease
- Study of Deferasirox, an oral iron chelator
- Screening for pulmonary hypertension and a randomized study of Sildenafil for the treatment of pulmonary hypertension
- Randomized study of inhaled nitric oxide for the treatment of vasocclusive pain crisis
Past Studies:
- Core decompression for Avascular Necrosis of the hip
- Neurocognitive functioning in school-aged children with sickle cell disease
- Language acquisition in Sickle Cell Disease in children ages 1-4 years
- Flocor - Intravenous pain management additive
- Study of acute chest syndrome in Sickle Cell Disease
- Conversion to Hepatitis B Vaccine in patients with Sickle Cell Disease
- Strep Pneumococcus Infections
- Adenosine Deaminase in patients with Sickle Cell Disease
Updated 5/29/07
